Figure 5.
Establishment of FA metabolism-related clinicopathologic nomogram. (A) Univariate Cox regression analysis of the signature FMI and clinical parameters. (B) Multivariate Cox regression analysis of the signature FMI and clinical parameters. (C) Development of a prognostic nomogram to predict 2-, 3-, and 5-year OS in BC patients of the training set. (D) Calibration curve to evaluate the consistency of predicted and actual OS. (E) Decision curve analysis (DCA) to assess the clinical decision-making benefits of the nomogram. FA, fatty acid; FMI, fatty acid metabolism index; OS, overall survival; BC, breast cancer.